Nexalin Technology (NXL) Stock Price, News & Analysis

Company Overview

Nexalin Technology, Inc. is a U.S.-based medical device company specializing in noninvasive neuromodulation therapies for mental health conditions. The company develops and markets the Nexalin® medical device platform, which delivers proprietary alternating current waveforms to targeted areas of the brain through forehead-mounted electrodes. Its technology is designed to modulate neural activity without pharmaceuticals, positioning the company within the growing field of digital therapeutics and neurostimulation.

The Nexalin device has received U.S. Food and Drug Administration 510(k) clearance for the treatment of generalized anxiety disorder and is marketed to healthcare providers, including psychiatrists, primary care physicians and behavioral health clinics. The therapy protocol typically involves a series of short, in-office treatment sessions during which patients remain awake and alert. Nexalin also supports ongoing clinical research to explore additional applications such as depression and stress-related conditions.

Headquartered in the United States, Nexalin Technology distributes its devices and training programs through a network of authorized dealers and directly to healthcare institutions. The company focuses on expanding adoption among mental health professionals by combining its regulatory-cleared device with physician training, clinical support services and patient education materials. As interest grows in nonpharmacological approaches to mental health, Nexalin aims to broaden its footprint across outpatient clinics and other care settings nationwide.

Key Stats

• Today's Range: $1.23 to $1.55
• 50-Day Range: $0.72 to $1.86
• 52-Week Range: $0.64 to $4.49
• Volume: 1.78 million shs
• Average Volume: 1.51 million shs
• Market Capitalization: $23.12 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.00
• Consensus Rating: Hold

Nexalin Technology Stock Analysis - MarketRank™

Nexalin Technology scored higher than 56% of companies evaluated by MarketBeat, and ranked 142nd out of 324 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

Nexalin Technology has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

Nexalin Technology has a consensus price target of $5.00, representing about 273.1% upside from its current price of $1.34.

Amount of Analyst Coverage

Nexalin Technology has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Nexalin Technology is -1.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nexalin Technology is -1.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Nexalin Technology has a P/B Ratio of 4.79. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.58% of the float of Nexalin Technology has been sold short.

Short Interest Ratio / Days to Cover

Nexalin Technology has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nexalin Technology has recently decreased by 62.83%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nexalin Technology does not currently pay a dividend.

Dividend Growth

Nexalin Technology does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.58% of the float of Nexalin Technology has been sold short.

Short Interest Ratio / Days to Cover

Nexalin Technology has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nexalin Technology has recently decreased by 62.83%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.8 / 5
• News Sentiment: 0.92

News Sentiment

Nexalin Technology has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Business Services companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Nexalin Technology this week, compared to 1 article on an average week.

Search Interest

10 people have searched for NXL on MarketBeat in the last 30 days. This is an increase of 233% compared to the previous 30 days.

MarketBeat Follows

4 people have added Nexalin Technology to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Nexalin Technology insiders have not sold or bought any company stock.

Percentage Held by Insiders

25.26% of the stock of Nexalin Technology is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 0.65% of the stock of Nexalin Technology is held by institutions.

NXL Stock Analysis - Frequently Asked Questions

How have NXL shares performed this year?

Nexalin Technology's stock was trading at $2.76 at the beginning of 2025. Since then, NXL shares have decreased by 51.4% and is now trading at $1.34.

How were Nexalin Technology's earnings last quarter?

Nexalin Technology, Inc. (NASDAQ:NXL) released its quarterly earnings data on Wednesday, August, 6th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.14) by $0.04. The company had revenue of $0.07 million for the quarter, compared to analysts' expectations of $0.04 million. Nexalin Technology had a negative net margin of 5,057.14% and a negative trailing twelve-month return on equity of 209.20%.

When did Nexalin Technology IPO?

Nexalin Technology (NXL) raised $10 million in an initial public offering (IPO) on Friday, September 16th 2022. The company issued 2,315,000 shares at a price of $4.15 per share.

How do I buy shares of Nexalin Technology?

Shares of NXL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Nexalin Technology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Nexalin Technology investors own include Meta Platforms (META), NVIDIA (NVDA), Faraday Future Intelligent Electric (FFIE), Intel (INTC), PayPal (PYPL), Advanced Micro Devices (AMD) and DoorDash (DASH).

Company Calendar

• Last Earnings: 8/06/2025
• Today: 10/10/2025
• Next Earnings (Estimated): 11/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Technology Services
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:NXL
• CIK: 1527352
• Web: www.nexalin.com
• Phone: 832-260-0222
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Nexalin Technology: $5.00
• High Price Target: $5.00
• Low Price Target: $5.00
• Potential Upside/Downside: +233.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.76)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$7.61 million
• Net Margins: -5,057.14%
• Pretax Margin: -5,057.14%
• Return on Equity: -209.20%
• Return on Assets: -186.87%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 10.43
• Quick Ratio: 10.14

Sales & Book Value

• Annual Sales: $170 thousand
• Price / Sales: 155.74
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.28 per share
• Price / Book: 5.36

Miscellaneous

• Outstanding Shares: 17,650,000
• Free Float: 13,189,000
• Market Cap: $26.48 million
• Optionable: Not Optionable
• Beta: 3.59